Metabolic rate is lower in this group, so caloric deficit management requires more attention
And for the guideline bodies: The precision-medicine framework applied to oncology and cardiology has not yet reached metabolic pharmacology
To stay ahead of this shifting environment, pharma companies should consider the following imperatives: Massive patient drop-off undermines obesity GLP-1 uptake: Despite strong demand, only 10% of obesity patients persist with therapy after one year
GLP-1 weight loss medication may help reduce appetite, but long-term success still requires nutrition, hydration, protein, habit change, monitoring, mindset support, and daily reinforcement
In conjunction with healthy eating habits and exercise, tirzepatide can empower you in your weight loss journey.